Filing Details
- Accession Number:
- 0001179110-22-003108
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-05-20 17:03:56
- Reporting Period:
- 2022-05-16
- Accepted Time:
- 2022-05-20 17:03:56
- Original Submission Date:
- 2022-05-18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551152 | Abbvie Inc. | ABBV | Pharmaceutical Preparations (2834) | 320375147 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1659625 | O Henry Gosebruch | 1 N. Waukegan Road North Chicago IL 60064 | Evp, Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2022-05-16 | 83,960 | $54.86 | 125,583 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-05-16 | 83,960 | $155.00 | 41,623 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2022-05-16 | 83,960 | $54.86 | 83,960 | $54.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-18 | 2026-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.01 Par Value | 53,500 | Indirect | In trust |
| Common Stock, $0.01 Par Value | 3,638 | Indirect | Profit sharing trust |
Footnotes
- The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
- Balance in AbbVie Savings program as of May 18, 2022.
- Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
